Categories: DiagnosticsNews

My Quest Story – James Murphy, Jr.

NORTHAMPTON, MA / ACCESSWIRE / January 8, 2025 / Quest Diagnostics

I’ve only been at Quest Diagnostics for one year, but I’m Team Quest. I don’t plan on leaving.

I’ve been mastering music and creating beats since 1998. I like R&B and techno. But after COVID hit, I was looking to do something new and wanted a job where I could be active.

After trying to drive and deliver with a few companies and working graveyard shifts, Quest reached out to me.

I said to myself, “That sounds like a good job.” I applied and it has worked out for me.

I’m an advanced swing route services representative, which means I know every route. I can cover any route if there is a call-out or someone is on vacation. I am a fast learner, and this keeps things from getting boring.

I am walking sometimes 10,000 to 15,000 steps a day now. I am outside and talking to people. I’m not the type of person who could do the same route and same thing every day. I would stagnate. I like working mornings, nights, weekends. I like to move around and keep going. I’m never the “no” guy. To me, it isn’t a hard job – it’s fun.

No matter what kind of music you make, it’s about mastering it. That’s what I’m doing at Quest. I’m always looking to improve my skill level and keep things interesting.

Interested in a purpose-driven career? Check out the Quest Careers site: Working at Quest Diagnostics

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics

View the original press release on accesswire.com

Staff

Recent Posts

Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates

Ad hoc announcement pursuant to Art. 53 LR Revenue Growth: Full-year 2024 revenue of €265.7…

4 hours ago

RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has…

6 hours ago

ITRI Opens CES 2025 With Trend-Leading Showcase and Partnership With Reliance Biotech Corporation

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) initiated its presence…

6 hours ago

NOTICE OF DATA BREACH

LOS ANGELES, Jan. 8, 2025 /PRNewswire/ -- Dear members of the STIIIZY community:  Stiiizy, Inc.…

6 hours ago

Ascent Strategy Group Recognized by Modern Healthcare’s Best in Business, Affirms Health Equity Mission Amid Alarming Disparities

Agency Founder nominated Outstanding Agency Professional, Innovator of the Year First public relations agency built…

6 hours ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options

VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or…

9 hours ago